These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29035899)

  • 21. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
    Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
    Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices.
    Mutsuga M; Okumura T; Morimoto R; Kondo T; Ito H; Terazawa S; Tokuda Y; Narita Y; Nishida K; Murohara T; Usui A
    Artif Organs; 2023 Feb; 47(2):387-395. PubMed ID: 36269680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex HeartMate II infection treated with pump exchange to HeartWare HVAD.
    Abicht T; Gordon R; Meehan K; Stosor V; McCarthy P; McGee E
    ASAIO J; 2013; 59(2):188-92. PubMed ID: 23438785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation.
    Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M
    Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel driveline route for prevention from driveline infection: Triple tunnel method.
    Yoshitake S; Kinoshita O; Nawata K; Hoshino Y; Itoda Y; Kimura M; Yamauchi H; Ono M
    J Cardiol; 2018 Oct; 72(4):363-366. PubMed ID: 29731190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing driveline infections in patients supported on ventricular assist devices: a care pathway approach.
    Seretny J; Pidborochynski T; Buchholz H; Freed DH; MacArthur R; Dubyk N; Cunliffe L; Zelaya O; Conway J
    BMJ Open Qual; 2022 May; 11(2):. PubMed ID: 35649636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study.
    Pitton M; Valente LG; Oberhaensli S; Casanova C; Sendi P; Schnegg B; Jakob SM; Cameron DR; Que YA; Fürholz M
    J Heart Lung Transplant; 2023 Oct; 42(10):1445-1454. PubMed ID: 37245557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Treatment for Driveline Infection Following Implantation of a Ventricular Assist Device.
    Sezai A; Unosawa S; Taoka M; Osaka S; Kitazumi Y; Suzuki K; Nakai T; Tanaka M
    Heart Surg Forum; 2020 Mar; 23(2):E132-E134. PubMed ID: 32364899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Success With Driveline Exit Site Relocation for Deep Driveline Infection in Left Ventricular Assist Device Patients.
    Balsam LB; Jacoby A; Louie E; Levine JP
    Innovations (Phila); 2017; 12(6):440-445. PubMed ID: 29232297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantial Reduction in Driveline Infection Rates With the Modification of Driveline Dressing Protocol.
    Lander MM; Kunz N; Dunn E; Althouse AD; Lockard K; Shullo MA; Kormos RL; Teuteberg JJ
    J Card Fail; 2018 Nov; 24(11):746-752. PubMed ID: 30098380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Infection and Antimicrobial Consumption in Ventricular Assist Device (VAD) Recipients at the Prince Charles Hospital (TPCH): A Retrospective Analysis.
    Belz S; Fisquet S; Ahuja A; Hay K; Lavana J
    Heart Lung Circ; 2020 Aug; 29(8):1234-1240. PubMed ID: 32179022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Gallium-SPECT-CT in the Management of Patients With Ventricular Assist Device-Specific Percutaneous Driveline Infection.
    Kimura Y; Seguchi O; Mochizuki H; Iwasaki K; Toda K; Kumai Y; Kuroda K; Nakajima S; Tateishi E; Watanabe T; Matsumoto Y; Fukushima S; Kiso K; Yanase M; Fujita T; Kobayashi J; Fukushima N
    J Card Fail; 2019 Oct; 25(10):795-802. PubMed ID: 31454687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical management of driveline infections in patients with left ventricular assist devices.
    Pieri M; Scandroglio AM; Müller M; Pergantis P; Kretzschmar A; Kaufmann F; Falk V; Krabatsch T; Arlt G; Potapov E; Kukucka M
    J Card Surg; 2016 Dec; 31(12):765-771. PubMed ID: 27766677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Driveline infection according to driveline positioning in left ventricular assist device implant recipients.
    Lauenroth V; Zittermann A; Lucke S; Gummert JF; Morshuis M
    Int J Artif Organs; 2024 Feb; 47(2):118-121. PubMed ID: 38182556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous Driveline Fracture After Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair?
    Stulak JM; Schettle S; Haglund N; Dunlay S; Cowger J; Shah P; Aaronson KD; Pagani FD; Maltais S
    ASAIO J; 2017; 63(5):542-545. PubMed ID: 28125463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center.
    Hamad Y; Blanco-Guzman MO; Olsen MA; Wang X; Vader J; Verma A; Dubberke ER
    Transpl Infect Dis; 2021 Aug; 23(4):e13686. PubMed ID: 34251073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests.
    Kranzl M; Stoiber M; Schaefer AK; Riebandt J; Wiedemann D; Marko C; Laufer G; Zimpfer D; Schima H; Schlöglhofer T
    Front Cardiovasc Med; 2021; 8():784208. PubMed ID: 34977190
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.